The price cut brings the cost down to 2008 levels, the drugmaker said, and will apply to all Eli Lilly’s non-branded insulins.
The list price for insulin lispro will be $82.41 for individual vials and $159.12 for a pack of five pens.
Eli Lilly said people who face higher out-of-pocket costs, such as those without insurance or with high deductible health plans, will benefit the most from the price drop.
Read the full news release here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
